Ribosomal protein L21 pseudogene 129 (RPL21P129)

Ribosomal protein L21 pseudogene 129 (RPL21P129) is classified as a pseudogene, meaning it is a non-functional segment of DNA resembling the ribosomal protein L21 gene but does not encode an active protein. Pseudogenes typically arise from duplication or retrotransposition events and are unable to produce a functional protein product due to mutations or lack of regulatory sequences. There is no known biological function, disease association, or implication as a drug target for RPL21P129. Its main utility is as a genomic marker to study evolutionary processes or gene family organization. RPL21P129 is explicitly annotated as a pseudogene, not a coding gene. It is related to ribosomal protein L21 (a protein-coding gene), but pseudogenes generally lack function. There is no evidence in the literature or databases of RPL21P129 being a therapeutic target, associated with disease, or being pharmacologically relevant. As a pseudogene, it is not considered a valid therapeutic target, does not encode a functional protein, and has no current relevance to disease or drug mechanism. If the intention was to select the functional ribosomal protein L21 (RPL21), a correction would be needed, as RPL21 is the active gene.

Other names

RPL21_60_1619RPL21P129